In the media

Back to news lobby
Back to news lobby
In the Media 6 mins
January 13, 2023

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer.

Itai Hayut, CEO of healthtech company Scopio Labs, on how AI & digitalisation help in the detection of blood related cancers, anaemia & allergies. Scopio Labs is a healthtech company that’s transforming cell...
Link to full article

Itai Hayut, CEO of healthtech company Scopio Labs, on how AI & digitalisation help in the detection of blood related cancers, anaemia & allergies. Scopio Labs is a healthtech company that’s transforming cell morphology analysis, offering a suite of fully digital diagnostic applications and platforms that enhance clinical workflows, turnaround times, and lab efficiencies for the benefit of patients.

Back to news lobby
Latest press releases and coverage
Press Release
September 17, 2024

Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

We are thrilled to announce the expansion of our long-term partnership with Beckman Coulter Diagnostics to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA)...
Read more
Press Release
July 25, 2024

Scopio Labs Secures $42 Million in Funding Led by Fortissimo Capital

New Funding to Accelerate Scopio Labs' Commercial Growth and Product Innovation in Full-Field Digital Cell Morphology
Read more
Press Release
April 17, 2024

Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application

The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care.
Read more

Experience high resolution digital imaging and AI-driven full-field analysis

Book a demo